Pharmaceutical company leaves New York for Florida

The relocation of New York-based Beacon Pharmaceutical to Florida will create a biotech “accelerator” that will provide both capital and mentoring to as many as 50 companies and employ as many as 200 within five or so years, according to Philippe Gaston, Beacon Pharmaceutical CEO, who will oversee the initiative. Beacon has committed to create 137 jobs with average annual salaries of more than $70,000. The company plans to build a 200,000-square-foot headquarters in Florida, making a total capital investment of about $80 million.

Thirty-eight companies are already in discussion with Beacon to locate to the accelerator.

Leave a Reply